JP2018512154A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512154A5
JP2018512154A5 JP2017553230A JP2017553230A JP2018512154A5 JP 2018512154 A5 JP2018512154 A5 JP 2018512154A5 JP 2017553230 A JP2017553230 A JP 2017553230A JP 2017553230 A JP2017553230 A JP 2017553230A JP 2018512154 A5 JP2018512154 A5 JP 2018512154A5
Authority
JP
Japan
Prior art keywords
cell
subject
composition
chimeric protein
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017553230A
Other languages
English (en)
Japanese (ja)
Other versions
JP6704411B2 (ja
JP2018512154A (ja
Filing date
Publication date
Priority claimed from GBGB1506223.5A external-priority patent/GB201506223D0/en
Application filed filed Critical
Publication of JP2018512154A publication Critical patent/JP2018512154A/ja
Publication of JP2018512154A5 publication Critical patent/JP2018512154A5/ja
Application granted granted Critical
Publication of JP6704411B2 publication Critical patent/JP6704411B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017553230A 2015-04-13 2016-04-12 キメラタンパク質 Expired - Fee Related JP6704411B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1506223.5A GB201506223D0 (en) 2015-04-13 2015-04-13 Chimeric protein
GB1506223.5 2015-04-13
PCT/GB2016/051019 WO2016166521A1 (en) 2015-04-13 2016-04-12 Chimeric protein

Publications (3)

Publication Number Publication Date
JP2018512154A JP2018512154A (ja) 2018-05-17
JP2018512154A5 true JP2018512154A5 (https=) 2019-02-28
JP6704411B2 JP6704411B2 (ja) 2020-06-03

Family

ID=53333686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017553230A Expired - Fee Related JP6704411B2 (ja) 2015-04-13 2016-04-12 キメラタンパク質

Country Status (10)

Country Link
US (1) US10869911B2 (https=)
EP (1) EP3283526B1 (https=)
JP (1) JP6704411B2 (https=)
CN (1) CN107531804A (https=)
AU (1) AU2016250200B2 (https=)
CA (1) CA2981846A1 (https=)
ES (1) ES2749903T3 (https=)
GB (1) GB201506223D0 (https=)
HK (1) HK1243107B (https=)
WO (1) WO2016166521A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201519900D0 (en) * 2015-11-11 2015-12-23 Ucl Business Plc Chimeric antigen receptor
CN108395482B (zh) 2017-02-08 2021-02-05 西比曼生物科技（香港）有限公司 一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
GB201716728D0 (en) 2017-10-12 2017-11-29 Autolus Ltd Cell
AU2019403393B2 (en) * 2018-12-20 2026-04-16 The University Of Chicago Methods and compositions related to therapeutic peptides for cancer therapy
WO2021102250A1 (en) * 2019-11-21 2021-05-27 Luppino Francesco Growth factor restoration
CN113402612A (zh) 2020-03-17 2021-09-17 西比曼生物科技（香港）有限公司 靶向cd19和cd20的联合嵌合抗原受体及其应用
WO2021198163A1 (en) * 2020-04-01 2021-10-07 Medigene Immunotherapies Gmbh Cd3-fusion protein and uses thereof
EP4199947A4 (en) 2020-08-18 2024-10-16 Onchilles Pharma, Inc. Modified porcine pancreatic elastase proteins
JP2024527882A (ja) * 2021-07-21 2024-07-26 コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー 新規のキメラ抗原受容体及びそれを発現する免疫細胞
AU2023400596A1 (en) * 2022-11-29 2025-06-19 Malcorp Biodiscoveries Limited Novel cd20 protein
CA3278900A1 (en) 2023-03-31 2024-10-03 AbelZeta Inc. BISPECIFIC CHIMERIC ANTIGENIC RECEPTORS TARGETING CD20 AND BCMA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914650D0 (en) * 1999-06-24 1999-08-25 Angyogene Pharmaceuticals Ltd Chimeric proteins mediating targeted apoptosis
US9382327B2 (en) 2006-10-10 2016-07-05 Vaccinex, Inc. Anti-CD20 antibodies and methods of use
DK2496698T3 (en) * 2009-11-03 2019-04-15 Hope City TRUNCATED EPIDERIMAL GROWTH FACTOR RECEPTOR (EGFRt) FOR TRUNCATED T-CELL SELECTION
ES2649991T3 (es) 2012-11-19 2018-01-16 Baliopharm Ag Anticuerpo biespecífico recombinante que se une a CD20 y CD95
JP2017100947A (ja) * 2014-03-31 2017-06-08 株式会社オーダーメードメディカルリサーチ 目的抗原に対する抗体の作製方法

Similar Documents

Publication Publication Date Title
JP2018512154A5 (https=)
JP6997267B2 (ja) 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体
CN112638947B (zh) 用于治疗实体瘤的嵌合抗原受体细胞
Sommermeyer et al. Fully human CD19-specific chimeric antigen receptors for T-cell therapy
JP7029401B2 (ja) 抗ｒｏｒ１抗体およびその使用
JP6886491B2 (ja) 前立腺特異幹細胞抗原に対する抗体およびその使用
JP6196338B2 (ja) 診断および治療のための腫瘍関連抗原の同定
JP7395249B2 (ja) 細胞
KR102875986B1 (ko) Il27 수용체 결합과 관련된 조성물 및 방법
EP3378488A1 (en) Method for enhancing humoral immune response
KR20110066195A (ko) 종간특이적 ｐｓｍａｘｃｄ3 이중특이적 단쇄 항체
KR20090021217A (ko) 조혈 줄기세포 증가 촉진제
CN115698081A (zh) 靶向bcma的嵌合抗原受体及其用途
JP7839238B2 (ja) ｍＲＮＡディスプレイ抗体ライブラリー及び方法
CN118871471A (zh) 用于肿瘤靶向的嵌合抗原受体
US20240263355A1 (en) mRNA display antibody library and methods
Rutkowski et al. Clr-a: a novel immune-related C-type lectin-like molecule exclusively expressed by mouse gut epithelium
TW201111510A (en) Recombinant nucleotide sequence, cell or vector containing the recombinant nucleotide sequence, recombinant single chain anti-polyethylene glycol membrane antibody encoded thereof and method for using the cell containing the recombinant nucleotide sequen
BR112020016374A2 (pt) Métodos e composições para direcionar células treg
KR20230124912A (ko) 키메라 수용체 및 이의 사용 방법
JP2023516089A (ja) がんの治療のための組成物及び方法
US20240228620A1 (en) Multispecific proteins and related methods
CN111393527B (zh) 可结合pd-l1的多肽及其应用
NL2021037B1 (en) TEIPP neoantigens and uses thereof
JP2026511106A (ja) 抗クローディン－１抗体を使用したがん治療のためのバイオマーカー